Atlas Trials

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer

Clinical trial NCT01958021 · COMPLETED

Trial details

NCT number
NCT01958021
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced, Metastatic Breast Cancer
Start date
2013-12-17
Primary completion
2016-01-29
Enrollment
668

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.